116 related articles for article (PubMed ID: 9457985)
1. Successful treatment of recurrent uterine bleeding during tamoxifen therapy by endometrial ablation.
Römer T
Int J Gynaecol Obstet; 1995 Apr; 49(1):51-2. PubMed ID: 9457985
[TBL] [Abstract][Full Text] [Related]
2. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
[TBL] [Abstract][Full Text] [Related]
3. [Endometrial ablation versus hysterectomy in women treated with tamoxifen].
Capuano I; Caporale A; Vagnetti P; Di Domenico A; Felicetti M; Torella M; Borrelli AL
Minerva Ginecol; 2007 Oct; 59(5):499-504. PubMed ID: 17912176
[TBL] [Abstract][Full Text] [Related]
4. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Zhu Y; Yang J
J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697
[TBL] [Abstract][Full Text] [Related]
5. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
6. Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy.
Ito T; Katagiri C; Murata Y; Hamazoe R; Morita K
J Obstet Gynaecol Res; 2001 Jun; 27(3):141-5. PubMed ID: 11561830
[TBL] [Abstract][Full Text] [Related]
7. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
8. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography.
Jaeger BM; Grumbach K
Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952
[TBL] [Abstract][Full Text] [Related]
10. Local levonorgestrel to prevent tamoxifen-related endometrial lesions.
Neven P
Lancet; 2000 Nov; 356(9243):1698-9. PubMed ID: 11095251
[No Abstract] [Full Text] [Related]
11. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
Reslová T; Tosner J; Vávrová I; Resl M
Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
[TBL] [Abstract][Full Text] [Related]
12. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial.
Gardner FJ; Konje JC; Abrams KR; Brown LJ; Khanna S; Al-Azzawi F; Bell SC; Taylor DJ
Lancet; 2000 Nov; 356(9243):1711-7. PubMed ID: 11095258
[TBL] [Abstract][Full Text] [Related]
13. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
[TBL] [Abstract][Full Text] [Related]
15. Endometrial tubal metaplasia in a young puerperal woman after breast cancer.
Di Benedetto L; Giovanale V; Caserta D
Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678
[TBL] [Abstract][Full Text] [Related]
16. Pathologic quiz case: postmenopausal vaginal bleeding in a woman treated for breast carcinoma.
Martinez AE; Robinson MJ
Arch Pathol Lab Med; 2003 May; 127(5):e261-2. PubMed ID: 12708930
[No Abstract] [Full Text] [Related]
17. Uterine ultrasound and endometrial biopsy in tamoxifen users.
Neven P; Froyman W; Timmerman S; Timmerman D
Breast Cancer Res Treat; 2020 Apr; 180(3):833-834. PubMed ID: 32180073
[No Abstract] [Full Text] [Related]
18. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
19. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Berlière M; Charles A; Galant C; Donnez J
Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
[TBL] [Abstract][Full Text] [Related]
20. Endometrial cancer and tamoxifen.
Burke C
Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
